Clostebol API Manufacturers & Suppliers
0 verified results
All Clostebol data. Full access. Full negotiation power
Commercial-scale Suppliers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
Clostebol | CAS No: 1093-58-9 | GMP-certified suppliers
A medication that serves as a synthetic androgen influencing masculine secondary sexual characteristics, intended for research and experimental applications in androgen-related therapies.
Therapeutic categories
Product Snapshot
- Clostebol is an anabolic androgenic steroid typically formulated as an oral or injectable small molecule
- It is primarily intended for muscle growth and performance enhancement
- The compound is experimental and not approved by major regulatory agencies such as the FDA or EMA
Clinical Overview
While clostebol has not been approved for therapeutic use in clinical practice, it is recognized primarily as an experimental agent and has been associated with illicit use, notably in contexts involving performance enhancement. The compound exerts androgenic activity through interaction with androgen receptors, modulating gene expression patterns that influence androgen-responsive tissues such as muscle and hair follicles. However, precise pharmacodynamic profiles and detailed mechanisms of action remain insufficiently characterized in the public domain.
Regarding absorption, distribution, metabolism, and excretion (ADME) properties, limited publicly available data preclude comprehensive description. As a steroidal compound, clostebol is likely to exhibit hepatic metabolism with potential for first-pass effect if administered orally, yet specific metabolic pathways and elimination routes require further elucidation.
Safety and toxicity data are likewise sparse, and given its androgenic nature, potential adverse effects may reflect those typical of androgen receptor agonists, including virilization, endocrine disruption, and liver toxicity. The absence of formal regulatory approval and detailed clinical evaluation underscores the need for caution in handling and usage.
Notable brands or pharmaceutical formulations are not available due to the lack of clinical authorization. From a sourcing perspective, procurement of clostebol API demands stringent quality control measures to assure identity, purity, and compliance with applicable regulatory frameworks. Suppliers should provide detailed certificates of analysis, and manufacturers must verify synthetic routes to exclude contamination with potentially hazardous impurities. Given its experimental and controlled status, adherence to local and international regulations on handling androgenic steroids is essential throughout the supply chain.
Identification & chemistry
| Generic name | Clostebol |
|---|---|
| Molecule type | Small molecule |
| CAS | 1093-58-9 |
| UNII | Z7D4G976SH |
| DrugBank ID | DB01521 |
Formulation & handling
- Clostebol is a small molecule androgen commonly formulated for oral administration due to its steroid structure and limited water solubility.
- The low water solubility suggests the need for solubilizing agents or appropriate vehicle selection during formulation to ensure bioavailability.
- Stability handling requires protection from moisture and light to maintain compound integrity during storage and processing.
Regulatory status
Clostebol is a type of Androgens
Androgens are a subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that play a crucial role in hormone replacement therapy and various other medical applications. They are a class of hormones that primarily include testosterone and its derivatives, which are responsible for the development and maintenance of male characteristics in the body.
Androgens are commonly used in the treatment of conditions such as hypogonadism, delayed puberty, androgen deficiency syndromes, and certain types of breast cancer. They work by binding to and activating the androgen receptors in cells, regulating gene expression and influencing the development and functioning of various tissues and organs.
Pharmaceutical companies produce androgens as API compounds to ensure precise dosage and efficacy in pharmaceutical formulations. These APIs undergo rigorous testing and quality control measures to meet regulatory standards and ensure patient safety.
The availability of androgens as APIs enables the formulation of different dosage forms such as tablets, injections, gels, and transdermal patches. These formulations provide healthcare professionals with various options for administration, allowing them to tailor treatment regimens according to individual patient needs.
It is essential for pharmaceutical companies to maintain strict quality control and adhere to Good Manufacturing Practices (GMP) during the production of androgens APIs. This ensures consistent potency, purity, and bioavailability of the APIs, ultimately leading to safe and effective medications for patients.
In conclusion, androgens are a vital subcategory of pharmaceutical APIs used in hormone replacement therapy and the treatment of various medical conditions. Their precise production and formulation allow for effective therapeutic interventions, promoting optimal patient outcomes.
Clostebol (Androgens), classified under Hormonal Agents
Hormonal agents are a prominent category of pharmaceutical active pharmaceutical ingredients (APIs) widely used in the medical field. These substances play a crucial role in regulating and modulating hormonal functions within the body. Hormonal agents are designed to mimic or manipulate the effects of naturally occurring hormones, allowing healthcare professionals to treat various endocrine disorders and hormonal imbalances.
Hormonal agents are commonly employed in the treatment of conditions such as hypothyroidism, hyperthyroidism, diabetes, and hormonal cancers. These APIs work by interacting with specific hormone receptors, either by stimulating or inhibiting their activity, to restore the balance of hormones in the body. They can be administered orally, intravenously, or through other routes depending on the specific medication and patient needs.
Pharmaceutical companies employ rigorous manufacturing processes and quality control measures to ensure the purity, potency, and safety of hormonal agent APIs. These APIs are synthesized using chemical or biotechnological methods, often starting from natural hormone sources or through recombinant DNA technology. Stringent regulatory guidelines are in place to guarantee the efficacy and safety of hormonal agent APIs, ensuring that patients receive high-quality medications.
As the demand for hormone-related therapies continues to grow, ongoing research and development efforts focus on enhancing the effectiveness and reducing the side effects of hormonal agent APIs. This includes the exploration of novel delivery systems, advanced formulations, and targeted drug delivery methods. By continuously advancing our understanding and capabilities in hormonal agents, the medical community can improve patient outcomes and quality of life for individuals with hormonal disorders.
